Mobile Health Solutions for more than 750 million people
With over 750 million people worldwide affected by lung impairments, and chronic lung diseases among the leading causes of death, the need for effective solutions is critical (and so close).
COPD, asthma, and long- or post-COVID impact millions globally. Mybreo provides innovative digital respiratory solutions, empowering individuals to improve their health and lead fuller, healthier lives.
Mobile Health Solutions for more than 750 million people
With over 750 million people worldwide affected by lung impairments, and chronic lung diseases among the leading causes of death, the need for effective solutions is critical (and so close).
COPD, asthma, and long- or post-COVID impact millions globally. Mybreo provides innovative digital respiratory solutions, empowering individuals to improve their health and lead fuller, healthier lives.
What is respiratory therapy?
Respiratory therapy has been scientifically proven to be effective. It consists of more than 100 exercises and techniques which, despite their intuitive application, are still rarely used by patients …and it is quite simple to digitalize.
Use cases for respiratory therapy
- Breaking the vicious cycle of COPD
- Improving the medical course of asthma
- Geriatric care
- Long and Post COVID therapy
- Preparation for and rehabilitation after thoracic surgeries
- Reducing the risk of pneumonia
- Treatment of acute lung infections
What is respiratory therapy?
Respiratory therapy has been scientifically proven to be effective. It consists of more than 100 exercises and techniques which, despite their intuitive application, are still rarely used by patients …and it is quite simple to digitalize.
Use cases for respiratory therapy
- Breaking the vicious cycle of COPD
- Improving the medical course of asthma
- Geriatric care
- Long and Post COVID therapy
- Preparation for and rehabilitation after thoracic surgeries
- Reducing the risk of pneumonia
- Treatment of acute lung infections
Mybreo milestones since foundation
Q1/23: Interviews
In our discovery phase and through personal interviews, we were able to precisely define the concerns and problems of our target groups.
Q2/23: Production
Based on the curriculum, we produced more than 100 interactive video learning units with one of Germany’s best-known breathing coaches.
Q3/23: €120.000 funding
As a project aligned with the UN Development Goals, we successfully secured MVP governmental funding through a program supported by the State of Berlin.
Q1/23: Interviews
In our discovery phase and through personal interviews, we were able to precisely define the concerns and problems of our target groups.
Q2/23: Production
Based on the curriculum, we produced more than 100 interactive video learning units with one of Germany’s best-known breathing coaches.
Q3/23: €120.000 funding
As a project aligned with the UN Development Goals, we successfully secured MVP governmental funding through a program supported by the State of Berlin.
Q4/23 The Web App
The finished app content goes online initially and finds its home under the domain mybreathing.de. The platform is unadvertised, but live.
Q2/24: MVP Soft Launch
The MVP of our program was launched in April 2024 and various marketing campaigns were launched at the same time.
Internationalisation & Diversification
The MVP is being tested in the international market, and B2B markets in Germany are being developed.
Q4/23 The Web App
The finished app content goes online initially and finds its home under the domain mybreathing.de. The platform is unadvertised, but live.
Q2/24: MVP Soft Launch
The MVP of our program was launched in April 2024 and various marketing campaigns were launched at the same time.
Internationalisation & Diversification
The MVP is being tested in the international market, and B2B markets in Germany are being developed.
Q1/23: Interviews
In our discovery phase and through personal interviews, we were able to precisely define the concerns and problems of our target groups.
Q2/23: Production
Based on the curriculum, we produced more than 100 interactive video learning units with one of Germany’s best-known breathing coaches.
Q3/23: 120.000€ Förderung
As a project aligned with the UN Development Goals, we successfully secured MVP governmental funding through a program supported by the State of Berlin.
Q4/23 The Web App
The finished app content goes online initially and finds its home under the domain mybreathing.de. The platform is unadvertised, but live.
Q2/24: MVP Soft Launch
The MVP of our program was launched in April 2024 and various marketing campaigns were launched at the same time.
Q4/24 Internationalisation & Diversification
The MVP is being tested in the international market, and B2B markets in Germany are being developed.
The Mybreo app
Based on the MVP content, the Mybreo app contains the following features
Based on the MVP content, the Mybreo app contains the following features
MyBreo’s digital companion empowers people globally to take control of their health and enhance their quality of life independently, with a variety of features and a highly gamified experience.
A digital companion
MyBreo’s digital companion empowers people globally to take control of their health and enhance their quality of life independently, with a variety of features and a highly gamified experience.
A digital companion
MyBreo’s digital companion empowers people globally to take control of their health and enhance their quality of life independently, with a variety of features and a highly gamified experience.
Market potential
The presentation refers to the use cases COPD, asthma and nursing homes.
Market potential
The presentation refers to the use cases COPD, asthma and nursing homes.
Multiple revenue streams due to diverse deployment options
- B2C sales of MVP in Germany, Austria and Switzerland
- B2B sale of individualized MVP to stationary care
- App Sales Germany, Austria and Switzerland (ARR)
- App sales with one-time fee
- Sale as a PreHa product (OP preparation)
Multiple revenue streams due to diverse deployment options
- B2C sales of MVP in Germany, Austria and Switzerland
- B2B sale of individualized MVP to stationary care
- App Sales Germany, Austria and Switzerland (ARR)
- App sales with one-time fee
- Sale as a PreHa product (OP preparation)
Multiple revenue streams due to diverse deployment options
- B2C sales of MVP in Germany, Austria and Switzerland
- B2B sale of individualized MVP to stationary care
- App Sales Germany, Austria and Switzerland (ARR)
- App sales with one-time fee
- Sale as a PreHa product (OP preparation)
€1m Targeted funding
€1m targeted funding
- Product development
- Avatarization, translation, internationalization
- Establishing the B2B market in Germany
- Market entry USA & UK
- Communication campaign expansion
- DTX Testing
- Preclinical trial processing
- Acquisition of additional state funding
€3 million capital from €500.000 investments
By raising more than €500,000, we will be able to obtain up to a further €2.5 million in capital from governmental funding.
Funding the next steps
- Product development
- Avatarization, translation, internationalization
- Establishing the B2B market in Germany
- Market entry USA & UK
- Communication campaign expansion
- DTX Testing
- Preclinical trial processing
- Acquisition of additional state funding
€3 million capital from €500.000 investments
By raising more than €500,000, we will be able to obtain up to a further €2.5 million in capital from governmental funding.
Want the full Pitch Deck?
Get more detailed insights and numbers straight into your mailbox.
- info@mybreo-health.com
Want the full Pitch Deck?
Get more detailed insights and numbers straight into your mailbox.
- info@mybreo-health.com